3 Stocks Pushing The Health Services Industry Higher

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

One out of the three major indices are trading up today with the Dow Jones Industrial Average (^DJI) trading down 17 points (-0.1%) at 12,949 as of Tuesday, Nov. 27, 2012, 11:49 AM ET. The NYSE advances/declines ratio sits at 1,707 issues advancing vs. 1,183 declining with 148 unchanged.

The Health Services industry currently sits up 0.1% versus the S&P 500, which is up 0.0%. A company within the industry that fell today was Life Technologies (LIFE), up 0.8%.

TheStreet Ratings group would like to highlight 3 stocks pushing the industry higher today:

3. Fresenius Medical Care Corporation (FMS) is one of the companies pushing the Health Services industry higher today. As of noon trading, Fresenius Medical Care Corporation is up $1.74 (2.6%) to $68.11 on heavy volume Thus far, 72,975 shares of Fresenius Medical Care Corporation exchanged hands as compared to its average daily volume of 74,500 shares. The stock has ranged in price between $67.02-$68.28 after having opened the day at $67.39 as compared to the previous trading day's close of $66.37.

Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides products and services for the treatment of end-stage renal disease worldwide. The company owns and operates dialysis clinics that provide dialysis treatment, and related laboratory and diagnostic services. Fresenius Medical Care Corporation has a market cap of $20.2 billion and is part of the health care sector. The company has a P/E ratio of 19.0, above the S&P 500 P/E ratio of 17.7. Shares are down 1.8% year to date as of the close of trading on Monday. Currently there are 5 analysts that rate Fresenius Medical Care Corporation a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Fresenius Medical Care Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, good cash flow from operations, expanding profit margins and reasonable valuation levels. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Fresenius Medical Care Corporation Ratings Report now.

Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade

1 2 3 Next › Last »

For more information on ResMed Inc. click any of the following:

• ResMed Inc. Stock Price

• ResMed Inc. Analyst Ratings

• ResMed Inc. Key Stats & Profile

• ResMed Inc. Earnings

• ResMed Inc. Ratio Comparison

• ResMed Inc. Growth Rates

• ResMed Inc. Balance Sheet

• ResMed Inc. Cash Flow

• ResMed Inc. Income Statement